Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptimmune Therapeutics

    NASDAQ: ADAP · Real-Time Price · USD
    0.28
    -0.00 (-1.06%)
    At close: Jun 09, 2025, 3:58 PM

    Adaptimmune Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 91.14M 143.99M 108.03M 149.95M
    Short-Term Investments
    		 60.47M 2.95M 96.57M 219.63M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 2.7M 3.03M 1.57M 1.72M
    Receivables
    		 15.98M 46.92M 38.09M 34.01M
    Inventory
    		 7.32M n/a n/a n/a
    Other Current Assets
    		 3.23M 3.74M 3.21M 2.83M
    Total Current Assets
    		 188.17M 207.55M 255.37M 415.46M
    Property-Plant & Equipment
    		 51.22M 71.71M 71.53M 51.37M
    Goodwill & Intangibles
    		 3.88M 330K 442K 1M
    Total Long-Term Assets
    		 57.79M 75.06M 73.55M 54.09M
    Total Assets
    		 245.96M 282.62M 328.92M 469.55M
    Account Payables
    		 8.69M 8.13M 4.75M 8.11M
    Deferred Revenue
    		 12.3M 28.97M 23.52M 22.2M
    Short-Term Debt
    		 4.71M n/a 2.73M 2.32M
    Other Current Liabilities
    		 21.46M 15.68M 12.67M 12.09M
    Total Current Liabilities
    		 64.53M 72.79M 64.5M 62.54M
    Long-Term Debt
    		 50.24M n/a 20.35M 23.15M
    Other Long-Term Liabilities
    		 4.27M 1.4M 1.3M 673K
    Total Long-Term Liabilities
    		 169.59M 170.31M 182.54M 201.04M
    Total Liabilities
    		 234.11M 243.1M 247.04M 263.58M
    Total Debt
    		 74.21M 25.23M 23.08M 25.47M
    Common Stock
    		 2.08M 1.86M 1.4M 1.34M
    Retained Earnings
    		 -1.09B -1.02B -909.3M -743.85M
    Comprehensive Income
    		 -1.9M -3.75M -875K -11.14M
    Shareholders Equity
    		 11.85M 39.51M 81.88M 205.96M
    Total Investments
    		 60.47M 2.95M 96.57M 219.63M

    Add to Watchlist